UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029689
Receipt number R000033812
Scientific Title The multi-center study of rotational allowance in total knee arthroplasty with Scorpio NRG
Date of disclosure of the study information 2017/10/25
Last modified on 2021/10/27 11:02:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The multi-center study of rotational allowance in total knee arthroplasty with Scorpio NRG

Acronym

NRG Multi-center study

Scientific Title

The multi-center study of rotational allowance in total knee arthroplasty with Scorpio NRG

Scientific Title:Acronym

NRG Multi-center study

Region

Japan


Condition

Condition

Knee Osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to demonstrate high rotational knee replacement implant minimize the impact of implant rotational alignment and achieve good outcome by evaluation of CT image, X-ray image and QOL.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Implant rotational alignment by CT image

Key secondary outcomes

Post-operative outcome (X-ray evaluation, JOA score, Knee Society Score (2011), and EQ-5D)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.The subject requires a primary total knee replacement.
2.The subject is diagnosed as knee osteoarthritis.
3.The subject is over 20 year of age.
4.The subject can walk independently without caregiver. (Including the subject with a cane.)
5.The subject has signed the IRB approved, study specific informed consent form.
6.The subject is willing to participate continuously in the study.

Key exclusion criteria

1.The subject who has an infection or is at high risk of having it.
2.The subject is revision case.
3.The subject who has had tibia osteotomy.
4.The subject who is morbidly obese. (BMI is 40 or more.)
5.The subject who is pregnant or potential pregnancy.
6.The subject has a neuromuscular or neurosensory deficiency that would limit the ability to assess.
7.The subject has a systemic disease that would limit the ability to assess.
8.The subject who has taken immunosuppressive agent or steroids consecutively that would limit the ability to assess.
9.The subject who is an inappropriate for participating in the study in the judgement of the investigator.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tetsuro Yasui

Organization

Teikyo University Hospital, Mizonokuchi

Division name

Orthopaedics

Zip code


Address

3-8-3, Mizonokuchi, Takatsu-ku, Kawasaki, Kanagawa

TEL

044-844-3333

Email

yasuit@med.teikyo-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoru Motohashi

Organization

Stryker Japan K.K.

Division name

Clinical Affairs

Zip code


Address

2-6-1, Koraku, Bunkyo-ku, Tokyo

TEL

03-6894-8394

Homepage URL


Email

NSKclinicaltrial@stryker.com


Sponsor or person

Institute

Stryker Japan K.K.

Institute

Department

Personal name



Funding Source

Organization

Stryker Japan K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

吉田総合病院(広島県)、坂下厚生総合病院(福島県)


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB

2017 Year 05 Month 29 Day

Anticipated trial start date

2017 Year 07 Month 24 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

- Rotation evaluation (CT image)
- Radiographic evaluation
- Functional score
- Patient's satisfaction


Management information

Registered date

2017 Year 10 Month 24 Day

Last modified on

2021 Year 10 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033812


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name